Read + Share
Bisecco A, Matrone F, Capobianco M, De Luca G, et al. COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing
of ocrelizumab in MS patients. J Neurol 2023 Nov 20. doi: 10.1007/s00415-023-12084.
PMID: 37982852
|
 |
|
Bisecco A, Matrone F, Capobianco M, De Luca G, et al. COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing
of ocrelizumab in MS patients. J Neurol 2023 Nov 20. doi: 10.1007/s00415-023-12084.
PMID: 37982852
|
|
|
|